• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
SURF

SURF

Surface Oncology, Inc.

NASDAQHealthcareBiotechnologyUS

USD1.07

-0.01 (-0.93%)

Company Profile

CEO

Lisa McGrath

IPO Date

2018-04-19

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$1.06

Prev. Close

$1.08

Day Low

$1.01

Day High

$1.09

52W Low

$0.56

52W High

$1.43

Market Cap

$0.07B

Volume

1.46M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

48.8%

Avg Negative

1.5%

Avg Neutral

49.9%

News Feed

ARK Investment Leans Into Biotech and Telecom Holdings

GuruFocus·7/12/2021·↑ positive

Surface Oncology Appoints Denice Torres to Board of Directors

GlobeNewsWire·7/8/2021·↑ positive

Surface Oncology's SRF388 Shows Promising Anticancer Activity in Pretreated Patients

Benzinga·6/4/2021·↑ positive

Surface Oncology, Roche Team Up to Develop SRF388 Combo Therapy for Liver Cancer

Benzinga·6/4/2021·↑ positive

SRF388, a First-in-Class IL-27 Antibody, Demonstrates Monotherapy Activity in Data Presented at American Society of Clinical Oncology Annual Meeting

GlobeNewsWire·6/4/2021·↑ positive

Surface Oncology to Collaborate with Roche on Immuno-Oncology Study Evaluating SRF388, Targeting IL-27, as Part of a Novel Combination in Patients with Advanced Treatment-naïve Hepatocellular Carcinoma

GlobeNewsWire·6/4/2021·↑ positive

This Is Why Surface Oncology Is a Great Stock to Buy Right Now

The Motley Fool·5/28/2021·↑ positive

Implied Volatility Surging for Surface Oncology (SURF) Stock Options

Zacks Investment Research·5/18/2021·↑ positive

Could Surface Oncology Be a Millionaire-Maker Stock?

The Motley Fool·5/16/2021·↑ positive

Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2021

GlobeNewsWire·5/5/2021·↑ positive